141 related articles for article (PubMed ID: 12556555)
1. Clinical-trial agreements between medical schools and industry.
Novak JW
N Engl J Med; 2003 Jan; 348(5):476-8; author reply 476-8. PubMed ID: 12556555
[No Abstract] [Full Text] [Related]
2. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.
Schulman KA; Seils DM; Timbie JW; Sugarman J; Dame LA; Weinfurt KP; Mark DB; Califf RM
N Engl J Med; 2002 Oct; 347(17):1335-41. PubMed ID: 12397192
[TBL] [Abstract][Full Text] [Related]
3. Medical schools found to vary in their drug-testing standards.
Dean C
N Y Times Web; 2005 May; ():A24. PubMed ID: 15981393
[No Abstract] [Full Text] [Related]
4. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
Mello MM; Clarridge BR; Studdert DM
Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
[TBL] [Abstract][Full Text] [Related]
5. Gag clauses in clinical-trial agreements.
Steinbrook R
N Engl J Med; 2005 May; 352(21):2160-2. PubMed ID: 15917381
[No Abstract] [Full Text] [Related]
6. Clinical-trial agreements between medical schools and industry.
Barnes M; Gallin KE
N Engl J Med; 2003 Jan; 348(5):476-8; author reply 476-8. PubMed ID: 12557871
[No Abstract] [Full Text] [Related]
7. The negotiation and development of a clinical trial agreement.
Finn PB
J Biolaw Bus; 2006; 9(2):21-7. PubMed ID: 17111523
[TBL] [Abstract][Full Text] [Related]
8. Academic medical centers' standards for clinical-trial agreements with industry.
Mello MM; Clarridge BR; Studdert DM
N Engl J Med; 2005 May; 352(21):2202-10. PubMed ID: 15917385
[TBL] [Abstract][Full Text] [Related]
9. Conflict-of-interest policies.
Topol EJ
N Engl J Med; 2001 Mar; 344(13):1017; author reply 1018. PubMed ID: 11280315
[No Abstract] [Full Text] [Related]
10. Clinical-trial agreements between medical schools and industry.
Meyer RE; Korn D
N Engl J Med; 2003 Jan; 348(5):476-8; author reply 476-8. PubMed ID: 12557872
[No Abstract] [Full Text] [Related]
11. Conflict-of-interest policies.
Ratain MJ; Sheridan ME
N Engl J Med; 2001 Mar; 344(13):1018. PubMed ID: 11280317
[No Abstract] [Full Text] [Related]
12. Conflict-of-interest policies.
Nurok M
N Engl J Med; 2001 Mar; 344(13):1017; author reply 1018. PubMed ID: 11280316
[No Abstract] [Full Text] [Related]
13. Clinical investigators and the pharmaceutical industry.
Bellin E
N Engl J Med; 2000 Aug; 343(7):511. PubMed ID: 10950676
[No Abstract] [Full Text] [Related]
14. Clinical investigators and the pharmaceutical industry.
Newman TJ
N Engl J Med; 2000 Aug; 343(7):510-1. PubMed ID: 10950675
[No Abstract] [Full Text] [Related]
15. A clinical trial in a developing country: many questions, few answers.
Kietinun S; Gupte MD; Sengupta A
Issues Med Ethics; 2003; 11(3):89-90. PubMed ID: 16335511
[No Abstract] [Full Text] [Related]
16. Sponsored research agreements, university and government licensing, and clinical trial agreements: special contractual and intellectual property rights considerations.
Somers JP
J Biolaw Bus; 2003; 6(4):5-13. PubMed ID: 15072054
[TBL] [Abstract][Full Text] [Related]
17. Data availability for industry sponsored trials: what should medical journals require?
Steinbrook R; Kassirer JP
BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
[No Abstract] [Full Text] [Related]
18. Small study on industry trial sponsorship leads to big questions about quality and bias.
Twombly R
J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
[No Abstract] [Full Text] [Related]
19. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
20. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
Dorfman HL; Reig LP
Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
